Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma

Journal of Pathology

Volumn 186, Issue 2, 1998, Pages 140-143

  Pilozzi, Emanuela ^a   Pulford, Karen ^a   Jones, Margaret ^a   Müller Hermelink, Hans Konrad ^b   Falini, Brunangelo ^c   Ralfkiaer, Elisabeth ^d   Pileri, Stefano ^e   Pezzella, Francesco ^f   De Wolf Peeters, Christine ^g   Arber, Daniel ^h   Stein, Harald ⁱ   Mason, David ^a   Gatter, Kevin ^a,j  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF PERUGIA   (Italy)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e UNIVERSITY OF BOLOGNA   (Italy)

^f Department of Histopathology   (United Kingdom)

^g UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^h CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

ⁱ FREIE UNIVERSITÄT BERLIN   (Germany)

^j JOHN RADCLIFFE HOSPITAL   (United Kingdom)

more..

Author keywords

CD3; CD79a; Lymphoblastic lymphoma

Indexed keywords

CD3 ANTIGEN; CD79 ANTIGEN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL MATURATION; CELL PROLIFERATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOBLASTOMA; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0031720541     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(1998100)186:2<140::AID-PATH149>3.0.CO;2-Y     Document Type: Article

References (29)

1. Cortes JE, Kantarjian HM. Acute lymphoblastic-leukemia - a comprehensive review with emphasis on biology and therapy. Cancer 1995; 76: 2393-2417.
2. Pui CH. Childhood leukemias. N Engl J Med 1995; 332: 1618-1630.
3. Pui CH, Behm FG, Crist WM. Clinical and biological relevance of immunological marker studies in childhood acute lymphoblastic-leukemia. Blood 1993; 82: 343-362.
4. Pui CH, Crist WM, Look AT. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic-leukemia. Blood 1990; 76: 1449-1463.
5. Matutes E. Contribution of immunophenotype in the diagnosis and classification of hematopoietic malignancies. J Clin Pathol 1995; 48: 194-197.
6. Mason DY, Cordell JL, Brown MH, et al. CD79a - a novel marker for B-cell neoplasms in routinely processed tissue samples. Blood 1995; 86: 1453-1459.
7. Mason DY, Cordell JL, Tse A, et al. The IgM-associated protein mb-1 as a marker of normal and neoplastic B-cells. J Immunol 1991; 147: 4045.
8. Mason DY, Cordell J, Brown M, et al. Detection of T-cells in paraffin wax-embedded tissue using antibodies against a peptide sequence from the CD3 antigen. J Clin Pathol 1989; 42: 1194-1200.
9. Launder TM, Bray RA, Stempora L, Chenggis ML, Farhi DC. Lymphoid-associated antigen expression by acute myeloid leukemia. Am J Clin Pathol 1996; 106: 185-191.
10. Drexler HG, Thiel E, Ludwig WD. Acute myeloid leukemias expressing lymphoid-associated antigens - diagnostic incidence and prognostic significance. Leukemia 1993; 7: 489-498.
11. Matutes E, Morilla R, Farahat N, et al. Definition of acute biphenotypic leukemia. Haematologica 1997; 82: 64-66.
12. Carbonell F, Swansbury J, Min T, et al. Cytogenetic findings in acute biphenotypic leukemia. Leukemia 1996; 10: 1283-1287.
13. Uckun FM, Gaynon P, Sather H, et al. Clinical features and treatment outcome of children with biphenotypic CD2(+)CD19(+) acute lymphoblastic leukemia: a children's cancer group study. Blood 1997; 89: 2488-2493.
14. Brown DC, Gatter KC. The bone-marrow trephine biopsy - a review of normal histology. Histopathology 1993; 22: 411-422.
15. Cordell JL, Falini B, Erber WN, et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem, 1984; 32: 219-229.
16. Norton AJ, Jordan S, Yeomans P. Brief, high-temperature heat denaturation (pressure cooking) - a simple and effective method of antigen retrieval for routinely processed tissues. J Pathol 1994; 173: 371-379.
17. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
18. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
19. Sawyers CL, Denny CT, Witte ON. Leukemia and the disruption of normal hematopoiesis. Cell 1991; 64: 337-350.
20. Pui CH, Crist WM. Biology and treatment of acute lymphoblastic-leukemia. J Pediatrics 1994; 124: 491-503.
21. Reiter A, Schrappe M, Ludwig WD, et al. Chemotherapy in 998 unselected childhood acute lymphoblastic-leukemia patients - results and conclusions of the multicenter trial ALL-BFM-86. Blood 1994; 84: 3122-3133.
22. Pelicci PG, Knowles DM, Favera RD. Lymphoid tumors displaying rearrangements of both immunoglobulin and T-cell receptor genes. J Exp Med 1985; 162: 1015-1024.
23. Casares S, Rodriguez JM, Martin A, Parrado A. T-cell receptor gene rearrangements in lymphoid and non-lymphoid leukemias. Eur J Clin Invest 1994; 24: 119-125.
24. Kitchingman GR, Rovigatti U, Mauer AM, Melvin S, Murphy SB, Stass S. Rearrangement of immunoglobulin heavy-chain genes in T-cell acute lymphoblastic-leukemia. Blood 1985; 65: 725-729.
25. Clevers H, Alarcon B, Wileman T, Terhorst C. The T cell receptor/CD3 complex: a dynamic protein ensemble. Annu Rev Immunol 1988; 6: 629-662.
26. Borst J, Brouns GS, Devries E, Verschuren M, Mason DY, Vandongen J. Antigen receptors on T-lymphocyte and B-lymphocyte - parallels in organization and function. Immunol Rev 1993; 132: 49-84.
27. Buccheri V, Mihaljevic B, Matutes E, Dyer M, Mason DY, Catovsky D. mb-1 - a new marker for B-lineage lymphoblastic-leukemia. Blood 1993; 82: 853-857.
28. Shuster JJ, Falletta JM, Pullen DJ, et al. Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood 1990; 75: 166-173.
29. Pui CH, Behm FG, Singh B, et al. Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic-leukemia. Blood 1990; 75: 174-179.